KS

Kolli Surendra Reddy

Director Director DIN 02487384
DIN 02487384 First appointment Feb 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Kolli Surendra Reddy

Data last updated:

Kolli Surendra Reddy was a Director at Glukem Pharmaceuticals Private Limited (2009) and Director at Chaitra Formulations Private Limited (2014). The companies operate in Pharma and Chemicals.

DIN 02487384
Primary Designation Director
Industry Pharma
First Appointment 10 Feb 2009

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20092009Active
Chaitra Formulations Private Limited U24100TG2014PTC092370
Director17 Jan 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Glukem Pharmaceuticals Private Limited
Chaitra Formulations Private Limited
Premium access

Shareholding and investment profile for Kolli Surendra Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kolli Surendra Reddy

Kolli Surendra Reddy was first appointed on 10 Feb 2009 as Director at Glukem Pharmaceuticals Private Limited. The most recent appointment on record is 17 Jan 2014 at Chaitra Formulations Private Limited.

Kolli Surendra Reddy held 2 earlier board appointments: Glukem Pharmaceuticals Private Limited (Director, 10 Feb 2009 to 08 Dec 2009); Chaitra Formulations Private Limited (Director, 17 Jan 2014 to 25 Feb 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available